Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis
Clinical trial NCT01703078 · COMPLETED
Trial details
- NCT number
- NCT01703078
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-03-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.